NCT03955575View on ClinicalTrials.gov

Treatment of Bile Acid Malabsorption With Liraglutide

PHASE4CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

March 7, 2019

Primary Completion Date

March 10, 2021

Study Completion Date

May 31, 2022

Conditions
Bile Acid Malabsorption
Interventions
DRUG

Liraglutide 6 MG/ML

Liraglutide as injections.

DRUG

Colesevelam

3 x 625 miligram 2 times a day.

Trial Locations (1)

2900

Gentofte Hospital, Hellerup

All Listed Sponsors
collaborator

Herlev and Gentofte Hospital

OTHER

lead

Filip Krag Knop

OTHER

NCT03955575 - Treatment of Bile Acid Malabsorption With Liraglutide | Biotech Hunter | Biotech Hunter